Mark Litzow

@DavidSteensma @ASH_hematology Hi, love the ASH crossword puzzle every year. Have you posted the 2024 answers yet?

The annual #ASH24 hematology-themed crossword puzzle - the 13th one that @ASH_hematology has let me share in the “ASH News Daily” conference newspaper. I’ll post the answers tomorrow…

Join us at Acute & Chronic Leukemias: Practical Applications 2023 on Oct. 6-7 in Orlando, FL (or via livestream). This year’s conference features interactive case presentations with panels of experts weighing in on pivotal treatment issues. Register here: tinyurl.com/ykcnhbhh

📣 #ESHALL2023 STARTS IN 1 MONTH! Don’t delay! REGISTER NOW & join us on May 19-21, 2023 in Berlin 🇩🇪 ➡ bit.ly/3JJxkXm 3rd Translational Research Conference: ACUTE LYMPHOBLASTIC LEUKAEMIA Chairs: @CoolsJn, @DombretHerve, @AdeleKFielding, @MRLitzow #ESHCONFERENCES #LEUsm

Please consider attending the 3rd Translational Research Conference on ALL in Berlin May 19-21, 2023. Great line up of translational and clinical talks at #ESHALL2023.

@AdeleKFielding Great first session. Looking forward to a wonderful meeting!

@MrinalPatnaik @ASH_hematology @raphaelitzykson @MoritzBinderMD @MayoClinicCIM @a_mangaonkar Wonderful to see! Congratulations to Mrinal and colleagues.

Very grateful to @ASH_hematology for giving due recognition to #MDSMPN overlap syndromes| Several exciting papers #CMML #JMML #MDSMPNRST| @raphaelitzykson Dacota study- lack of benefit of HMA in #MPNCMML @MoritzBinderMD ssRNA ssATAC in #ASXL1mtCMML @MayoClinicCIM

@MrinalPatnaik Very touching and beautiful, thank you! Mark

But why then, this inglorious end, For a science premised on art and soul, Compassion intrinsically built in, Why do we struggle to know when to stop? Or when to gracefully let dusk set in? To celebrate life we strive on end, But what of death with dignity,

As beads of sweat curl up on deflated brows, The cacophony in the room dims, As chest compressions stop, Resuscitation ceases, An eerie stillness gradually fills, There you stand, vulnerable and shaken, Your life in a hysterical spin, Your son it was that bravely fought,

Condolences to President Trump and his family on the death of his brother, Robert, yesterday.

@KB_McCullough @kutzke_jade Wonderful!

@MayoHemeOnc @MayoCancerCare @SidYadavMD Wonderful to see!

Congratulations, Dr Gangat! She is @MayoHemeOnc Hematology Teacher of the Year! Outgoing chief (and incoming breast and gyn onc here at @MayoCancerCare), @SidYadavMD, presents the plaque today! 🙌🌟

Randomizes trial reported at ASCO shows benefit of early integrated palliative care for patients undergoing induction chemotherapy for AML! meetinglibrary.asco.org/record/186130/…

@DavidSteensma @DanaFarber @TheLancetHaem Yes, thanks. See ASH statement last year on this. ASH Statement in Support of Palliative Blood Transfusions in Hospice Setting hematology.org/advocacy/polic…

One of the challenges we face for our patients with hematologic malignancies is that many hospice programs don’t allow blood products, yet blood products can give palliative benefit. My terrific @DanaFarber colleague Dr Ore Odejide and I wrote about this dilemma @TheLancetHaem

via @NYTimes, interesting article on unreliability of many antibody tests for SARS-COV-2. nytimes.com/2020/04/24/hea…

One silver lining of the pandemic...... nationalgeographic.com/science/2020/0…

@MrinalPatnaik @MayoHemeOnc @MPAlexanderMD @feldstej @sanamloghavi Yes,uremia (uremic frost)

Tiny white crystals on my skin I flake, with headaches and confusion sometimes I awake, with guanidinosuccinic acid my platelets I brake, with normal B12 and folate 6 lobed neutrophils I make.. what condition do I have? @MayoHemeOnc @MPAlexanderMD @feldstej @sanamloghavi

A lay statement from the New York Times on the unique pulmonary physiology of COVID-19. nytimes.com/2020/04/20/opi…

via @NYTOpinion nytimes.com/2020/04/20/opi…

Global Concert to celebrate coronavirus workers finale song youtube.com/watch?v=SYJCYr…

Yes, correct, it was R-ibrutinib. Thanks for clarifying!

Big year for CLL at ASH 2018! Alliance-led NCTN trial shows Ibrutinib superior to BR in elderly (Plenary session) and ECOG-ACRIN-led NCTN trial shows superiority of Ibrutinib over FCR (LBA Session). And Michael Hallek is giving Ham Wasserman lecture on CLL. @ASH_hematology